Hood River Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Hood River Capital Management’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-239,912	Closed	-$20.9M	–	187
2026 Q1	$20.9M	Buy	239,912 +2,869	+1%	+$279K	0.21%	112
2025 Q4	$25.4M	Buy	237,043 +1,207	+0.5%	+$128K	0.28%	100
2025 Q3	$23.8M	Sell	235,836 -307,852	-57%	-$28.6M	0.28%	95
2025 Q2	$34.4M	Sell	543,688 -115,743	-18%	-$7.09M	0.48%	73
2025 Q1	$34.9M	Buy	659,431 +15,740	+2%	+$873K	0.6%	70
2024 Q4	$36M	Buy	643,691 +29,093	+5%	+$1.61M	0.53%	75
2024 Q3	$32.2M	Buy	+614,598	New	+$29.4M	0.52%	73

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hood River Capital Management's RYTM Position: Q2 2026 in Review

Hood River Capital Management sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2026, closing a stake of 239,912 shares — an estimated $20.9M sold.

Hood River Capital Management first reported a position in RYTM in Q3 2024 and held it in 7 quarters. The position peaked at $36M in Q4 2024. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

Hood River Capital Management reported no remaining Rhythm Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Hood River Capital Management sold 239,912 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $20.9M.
Hood River Capital Management first reported a position in Rhythm Pharmaceuticals in Q3 2024 and held it in 7 quarters.
Hood River Capital Management's Rhythm Pharmaceuticals position peaked at $36M in Q4 2024.
304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Hood River Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.